Los Angeles biotech firm Pelage Pharmaceuticals raises a $120 million Series B round co-led by ARCH Venture Partners and ...

Discover eight key AI biotech deals that have been made so far in 2025, spotlighting where industry leaders are betting big.

Yeast doesn’t know it’s making humanity’s favorite molecule. In this episode, we explore how chemistry turns fruit juice into ...

Ever wondered what “artificial vanilla” actually means? In this episode, we take vanilla extract to chemistry class, chase ...

Scientists have discovered how leukemia cells outsmart a leading treatment and may have found a way to stop them. Scientists ...

Experts weigh in on whether at-home micro-current devices live up to their claims. Discover which tools actually sculpt, lift ...

A review of recent literature shows bioengineering is reshaping oncology, from synthetic biology to nanomedicine, but what's ...

Roche had approached Delhi High Court, accusing Natco of violating its Indian patent, before going to the Supreme Court with ...

The theatrical exploration into the concept of storage marks Black Cube Nomadic Art Museum’s 10th anniversary.

WASHINGTON (AP) — The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients – revving up ...

For those with specific mutation, scientists at La Jolla Institute for Immunology and Columbia were able to document actions of T-cells, providing possible target for new therapies.

TEL AVIV, Israel and OSLO, Norway, Sept. 29, 2025 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical development stage biopharmaceutical company pursuing life-changing therapies in ...